Archive for the ‘CMOs’ Category

LIVE from INFORMEX 2012: President Gilles Cottier Looks at the Past and Future of SAFC

Thursday, February 16th, 2012

It has been a busy week here at Informex 2012. As a show exhibitor, sponsor of the Informex Networking Lounge and Speed Networking Sessions, and as a participant in various presentations throughout the show, SAFC has maximized the time here in New Orleans.

Today, SAFC was the host of two important presentations: one being a press briefing given by President Gilles Cottier and the other a Tech Talk on cocrystallization technology by Professor Chris Frampton. SAFC Live will be back in the next few days with a wrap up and overview of the cocrystal technology from Chris. For the moment, we wanted to take time to highlight Gilles’ presentation that was made in front of such high level publications as C&EN, Pharmaceutical Technology, Chemical Week, and Manufacturing Chemist, to name a few.

(more…)

SAFC Offers Insight into ADCs for the Present and the Future

Thursday, February 9th, 2012

SAFC is just a few days away from arriving in New Orleans for Informex 2012. As an exhibitor and sponsor of the Informex Networking Lounge, SAFC will have various members of the executive and sales team onsite to discuss SAFC capabilities and technologies. In particular, SAFC will be available to discuss their capabilities surrounding the creation of antibody – drug conjugates (ADCs) which have recently received a lot of press as they become more relevant to the chemical and pharma industry.

Because of their potency, ADCs require a different level of manufacturing capabilities, and SAFC is one of a handful of companies that has made large investments in GMP manufacturing capabilities for antibody – drug conjugates. Here, SAFC Process Development Manager, Michael Bienkowski, talks to us about the ADC market and future prospects for SAFC in this area.

(more…)

SAFC’s Dave Backer Discusses the Full Line of SAFC PharmaGrade Products and Highlights the PharmaGrade MSX Product Capabilities

Friday, February 3rd, 2012

As SAFC continues to settle into 2012, there is plenty of planning and development going on across the global SAFC network. Leading into the first big tradeshow of the year, Informex 2012 in New Orleans, LA, SAFC has been focused on introducing a new line of products that take quality and security of supply chain to another level. Below, Dave Backer, SAFC Director of Business Development and Marketing, discusses what the PharmaGrade product portfolio, means for SAFC customers and why it is relevant to the market.

(more…)

BREAKING NEWS: BioReliance to Become Part of SAFC

Wednesday, February 1st, 2012

 

Today, Sigma Aldrich confirmed that the newly acquired BioReliance business will become part of SAFC, the custom manufacturing and services business unit of Sigma-Aldrich. SAFC President, Gilles Cottier noted that the acquisition would serve to increase the SAFC value proposition and positively leverage the company’s industrial media presence and biological testing capabilities for end user services and solutions.

(more…)

SAFC Featured in the Informex 2012 Blog

Friday, January 27th, 2012

SAFC Marketing Manager, Nick Johnson, talks about what SAFC is bringing to the “Big Easy” in 2012 and why Informex is a key annual event for SAFC. Please click here to read the full blog.

(more…)

SAFC Gets Ready to Take on the “Big Easy” at Informex 2012!

Tuesday, January 24th, 2012

SAFC wasted no time moving forward in 2012! As we ramp up for our first big show of the year, Informex 2012, we wanted to take some time to run through what we will have to offer leading up to and throughout the upcoming event in New Orleans, LA.

(more…)

Hot Off the Press: Sigma-Aldrich to Acquire BioReliance in Order to Extend into Biopharmaceutical Testing and Services

Monday, January 9th, 2012

Today, Sigma-Aldrich Corporation announced plans to acquire BioReliance Holdings for $350M. The acquisition is part of a strategic plan to extend the company’s biopharmaceutical testing and services and increase their value proposition to customers. The extension of these services will allow Sigma-Aldrich to more effectively provide enhanced solutions for its biopharmaceutical customers and also allows customers to work with a single point provider that is more vertically integrated throughout the drug discovery process. The full press release is available by clicking below. Stay tuned to SAFC Live as we provide updates on this new acquisition and what it means for the company and the industry.

(more…)